Prevention for the Development of Liver Tumorigenesis by the Oral Supplementation of Branched-chain Amino Acids
NCT01434524
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
56
Enrollment
OTHER
Sponsor class
Conditions
Liver Cancer
Interventions
DRUG:
LIVACT
Sponsor
Kochi University